amphetamine has been researched along with selegiline in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (17.05) | 18.7374 |
1990's | 46 (52.27) | 18.2507 |
2000's | 20 (22.73) | 29.6817 |
2010's | 6 (6.82) | 24.3611 |
2020's | 1 (1.14) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Reynolds, GP; Riederer, P; Sandler, M | 1 |
Blau, K; Elsworth, JD; Lees, AJ; Reynolds, GP; Sandler, M; Stern, GM | 1 |
Knoll, B; Knoll, J; Tímár, J | 1 |
Kuczenski, R; Okuda, C; Segal, DS | 1 |
Kraemer, T; Maurer, HH | 1 |
Baker, GB; Caffaro, LE; Coutts, RT; Greenshaw, AJ; Paetsch, PR; Rauw, GA | 1 |
Nag, M; Nandi, N | 1 |
Männistö, PT; Törnwall, M | 1 |
Dluzen, DE; McDermott, JL | 1 |
Knoll, B; Knoll, J; Timár, J; Yasar, S | 3 |
Salonen, JS | 1 |
Arbuthnott, GW; Butcher, SP; Fairbrother, IS; Kelly, JS | 1 |
Nickel, B; Schulze, G; Szelenyi, I | 2 |
Antonin, KH; Bieck, PR; Hoffmann, E; Jedrychowski, M; Nilsson, E; Schick, C; Schulz, R | 1 |
Kuroiwa, Y; Yamada, Y; Yamamoto, T; Yoshida, T | 1 |
Bretton, C; Hof, P; Ofori, S; Schorderet, M | 1 |
Salach, JI; Weyler, W | 1 |
Robinson, JB | 1 |
Philips, SR | 1 |
Dallo, J; Knoll, J; Yen, TT | 1 |
Hardie, R; Lees, AJ; Sandler, M; Stern, GM | 1 |
Hardie, RJ; Lees, AJ; Sandler, M; Stern, GM | 1 |
Jalfre, M; Pawelec, C; Porsolt, RD; Roux, S | 1 |
Coutts, RT; Foster, BC; Pasutto, FM | 1 |
Knoll, J; Zsilla, G | 1 |
Elsworth, JD; Lees, AJ; Sandler, M; Stern, GM; Ward, C | 1 |
Czurkó, A; Faludi, B; Karádi, Z; Knoll, J; Lénárd, L; Niedetzky, C; Vida, I | 1 |
Kikura, R; Nakahara, Y | 1 |
La Croix, R; Pianezzola, E; Strolin Benedetti, M | 1 |
Mahmood, I; Mason, WD; Neau, SH | 1 |
Bergman, J; Yasar, S | 1 |
Bhattacharya, N; Holland, D; Murray, B; Oh, C; Tatton, WG | 1 |
Gelowitz, DL; Lai, CT; Richardson, JS; Wishart, TB; Yu, PH | 1 |
Gyarmati, Z; Härsing, GL; Knoll, J; Tekes, K; Timár, J | 1 |
Dadgar, D; Mamer, OA; Reimer, ML; Siddiqui, AW; Zavitsanos, AP | 1 |
Greedan, A; Needleman, SB; Romberg, RW; Snyder, JJ | 1 |
Boulton, AA; Davis, BA; Fang, J; Lai, CT; Li, XM; Paterson, IA; Yu, PH; Zhang, X; Zuo, DM | 1 |
Gaál, J; Lengyel, J; Magyar, K; Szatmári, I; Szebeni, G; Székács, G | 1 |
Bosc, M; Deffond, D; Dordain, G; Dostert, P; Fiorentini, F; La Croix, R; Persiani, S; Strolin Benedetti, M; Vernay, D | 1 |
Lakshmana, MK; Munirathinam, S; Raju, TR | 1 |
Barna, L; Gyarmati, Z; Knoll, B; Timár, J | 1 |
Barrett, JS; De Witt, KE; Ireland, J; Morales, RJ; Rajewski, G; Rohatagi, S; Szego, P | 1 |
Cooper, T; Gaál, J; Hashim, A; Lajtha, A; Sershen, H | 1 |
Goldberg, JP; Goldberg, SR; Yasar, S | 1 |
Kikuta, C; Ludwig, G; Mascher, HJ; Millendorfer, A; Schiel, H | 1 |
Bernardi, G; Bonci, A; Mercuri, NB; Scarponi, M; Siniscalchi, A | 1 |
Behar, D; Schaller, JL | 1 |
Barrett, JS; DeWitt, KE; Morales, RJ; Rohatagi, S | 1 |
Barrett, JS; DeWitt, KE; Lessard, D; Morales, RJ; Rohatagi, S | 1 |
Báthori, M; Fürst, S; Hollósi, I; Kalász, H; Szebeni, G; Tarjányi, Z | 1 |
Wu, WR; Zhu, XZ | 1 |
Chaturvedi, AK; Kupiec, TC | 1 |
Bartók, T; Fürst, S; Haberle, D; Hennings, EC; Kalász, H; Kiss, JP; Magyar, K; Szöko, E | 1 |
Finberg, JP; Lamensdorf, I; Porat, S; Simantov, R | 1 |
Fukushima, S; Hasegawa, M; Kimura, K; Maseda, C; Matsubara, K; Uezono, T | 1 |
Caslavska, J; Ramseier, A; Thormann, W | 1 |
Kalász, H; Magyar, K; Szökö, E | 1 |
Gentsch, C; Spooren, WP; Waldmeier, P | 1 |
Bach, MV; Baker, GB; Coutts, RT | 1 |
Finberg, JP; Ilani, T; Lamensdorf, I | 1 |
Banchelli, G; Galeotti, N; Ghelardini, C; Pirisino, R; Raimondi, L | 1 |
Ahlner, J; Andersson, MC; Kronstrand, R; Larson, G | 1 |
Cody, JT | 1 |
Kamata, T; Katagi, M; Miki, A; Nakajima, K; Nishikawa, M; Nishioka, H; Tatsuno, M; Tsuchihashi, H; Tsutsumi, H | 1 |
Foltz, RL; Moody, DE; Slawson, MH; Taccogno, JL | 1 |
Knoll, B; Knoll, J; Miklya, I | 1 |
Ahlner, J; Dizdar, N; Kronstrand, R; Larson, G | 1 |
Magyar, K; Szöko, E; Tábi, T | 1 |
Brewer, F; Clarke, A; Corn, TH; Hartig, F; Johnson, ES; Mallard, N; Taylor, S | 1 |
Borbás, T; Dalmadi, B; Magyar, K; Szöko, E; Tábi, T; Tihanyi, K | 1 |
Mohanakumar, KP; Saravanan, KS; Senthilkumar, KS; Sindhu, KM | 1 |
Kinney, GG; Ransom, RW; Shughrue, PJ; Vanko, AE; West, BD | 1 |
Ikeda, N; Inoue, N; Itoh, S; Kudo, K; Nishida, K | 1 |
Lengyel, J; Magyar, K; Szatmáry, I; Szebeni, G | 1 |
Aoki, Y; Endo, S; Fujino, Y; Fujita, Y; Inoue, Y; Niitsu, H; Onodera, M; Takahashi, K; Takei, M | 1 |
Everhart, T; Harris, DS; Jacob, P; Jones, RT; Lin, E; Mendelson, JE | 1 |
Dimpfel, W; Hoffmann, JA; Müller, T; Oehlwein, C | 1 |
Magyar, K; Szökő, E; Tábi, T; Vécsei, L | 1 |
Bu, J; Qiao, Z; Shen, M; Wu, HJ; Xiang, P; Zhuo, XY | 1 |
Chen, L; Duan, G; Shen, B; Shi, Y; Wang, S; Xiang, P; Yan, H; Yu, Y | 1 |
Choi, H; Kang, S; Kim, J; Park, Y; Shin, I; Yang, W | 1 |
4 review(s) available for amphetamine and selegiline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Cell Count; Cerebral Cortex; Hippocampus; Mice; Monoamine Oxidase Inhibitors; Rats; Selegiline | 1995 |
Are metabolites of l-deprenyl (selegiline) useful or harmful? Indications from preclinical research.
Topics: Amphetamine; Animals; Biotransformation; Cocaine; Cognition; Conditioning, Operant; Drug Evaluation, Preclinical; Electroencephalography; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Nootropic Agents; Phenethylamines; Rats; Rats, Inbred F344; Reinforcement, Psychology; Saimiri; Selegiline; Self Administration | 1996 |
Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results.
Topics: Amphetamine; Amphetamines; Benzphetamine; Caffeine; Furans; Humans; Methamphetamine; Molecular Structure; Prenylamine; Prodrugs; Pyrazoles; Pyrazolones; Selegiline; Substance Abuse Detection; Sydnones; Theophylline | 2002 |
8 trial(s) available for amphetamine and selegiline
Article | Year |
---|---|
Deprenyl is metabolized to methamphetamine and amphetamine in man.
Topics: Amphetamine; Biotransformation; Humans; Male; Methamphetamine; Phenethylamines; Selegiline | 1978 |
Clinical and pharmacological aspects of (-)-deprenyl treatment in Parkinson's disease.
Topics: Amphetamine; Clinical Trials as Topic; Double-Blind Method; Humans; Hydrogen-Ion Concentration; Parkinson Disease; Phenethylamines; Selegiline | 1983 |
Lack of pharmacokinetic interaction between the selective dopamine agonist cabergoline and the MAO-B inhibitor selegiline.
Topics: Aged; Amphetamine; Amphetamines; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Drug Interactions; Ergolines; Female; Humans; Male; Methamphetamine; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline | 1995 |
Integrated pharmacokinetic and metabolic modeling of selegiline and metabolites after transdermal administration.
Topics: Administration, Cutaneous; Amphetamine; Amphetamines; Antiparkinson Agents; Area Under Curve; Humans; Male; Methamphetamine; Models, Biological; Monoamine Oxidase Inhibitors; Pilot Projects; Regression Analysis; Selegiline | 1997 |
Pharmacokinetic evaluation of a selegiline pulsatile oral delivery system.
Topics: Administration, Oral; Adult; Amphetamine; Amphetamines; Area Under Curve; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Delivery Systems; Humans; Intestinal Absorption; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Pilot Projects; Reference Values; Selegiline; Therapeutic Equivalency; Time Factors | 1997 |
Quantitative analysis of desmethylselegiline, methamphetamine, and amphetamine in hair and plasma from Parkinson patients on long-term selegiline medication.
Topics: Aged; Aged, 80 and over; Amphetamine; Amphetamines; Antiparkinson Agents; Drug Administration Schedule; Female; Hair; Hair Color; Humans; Male; Melanins; Methamphetamine; Middle Aged; Parkinson Disease; Patient Compliance; Selegiline; Spectrophotometry | 2003 |
A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
Topics: Administration, Oral; Adult; Aged; Amphetamine; Biological Availability; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Female; Humans; Hydroxyindoleacetic Acid; Male; Metabolic Clearance Rate; Methamphetamine; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Selegiline | 2003 |
A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.
Topics: Administration, Cutaneous; Adult; Affect; Amphetamine; Amphetamines; Analysis of Variance; Cocaine; Dopamine Uptake Inhibitors; Drug Interactions; Female; Homovanillic Acid; Humans; Infusions, Intravenous; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Monitoring, Physiologic; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Prolactin; Selegiline; Statistics, Nonparametric; Substance Withdrawal Syndrome; Young Adult | 2009 |
76 other study(ies) available for amphetamine and selegiline
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
2-Phenylethylamine and amphetamine in human brain: effects of L-deprenyl in Parkinson's disease [proceedings].
Topics: Amphetamine; Brain; Humans; Parkinson Disease; Phenethylamines; Selegiline; Tissue Distribution | 1979 |
(-)Deprenyl (selegiline) is devoid of amphetamine-like behavioural effects in rats.
Topics: Amphetamine; Animals; Avoidance Learning; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Escape Reaction; Female; Male; Motor Activity; Rats; Rats, Wistar; Selegiline; Stereotyped Behavior | 1992 |
Deprenyl alters behavior and caudate dopamine through an amphetamine-like action.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Behavior, Animal; Caudate Nucleus; Clorgyline; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Selegiline | 1992 |
Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abuse of
Topics: Amphetamine; Fluorescence Polarization Immunoassay; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; Selegiline; Stereoisomerism; Substance Abuse Detection | 1992 |
Electron-capture gas chromatographic procedure for simultaneous determination of amphetamine and N-methylamphetamine.
Topics: Amphetamine; Animals; Chromatography, Gas; Electrons; Gas Chromatography-Mass Spectrometry; Liver; Male; Methamphetamine; Rats; Rats, Inbred Strains; Selegiline | 1992 |
Antidepressants and brain respiration.
Topics: Amphetamine; Animals; Antidepressive Agents; Brain; Chlorides; Chlorpromazine; Clorgyline; Glucose; Imipramine; Lithium; Lithium Chloride; Male; Oxygen Consumption; Rats; Selegiline; Tranylcypromine | 1991 |
Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission.
Topics: Amphetamine; Animals; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catecholamines; Catechols; Clorgyline; Convulsants; Desipramine; Drug Interactions; Lethal Dose 50; Levodopa; Male; Mice; Motor Activity; Nitriles; Nomifensine; Pentanones; Selegiline; Synaptic Transmission; Yohimbine | 1991 |
The effect of long-term treatment with deprenyl on basal and L-dopa evoked dopamine release in vitro from the corpus striatum of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Corpus Striatum; Dopamine; In Vitro Techniques; Levodopa; Male; Rats; Selegiline | 1991 |
A (-) deprenyl-derived new spectrum psychostimulant.
Topics: Amphetamine; Animals; Brain Chemistry; Cefoxitin; Central Nervous System Stimulants; Dopamine; In Vitro Techniques; Motor Activity; Muscle, Smooth, Vascular; Phenethylamines; Rabbits; Rats; Selegiline; Synaptic Transmission | 1990 |
Determination of the amine metabolites of selegiline in biological fluids by capillary gas chromatography.
Topics: Amphetamine; Animals; Chromatography, Gas; Dogs; Methamphetamine; Phenethylamines; Selegiline | 1990 |
Comparison of the effects of (-)deprenyl, 1-phenyl-2-propyl-aminopentane (MK-306) and amphetamine on the striatal and limbic dopaminergic system.
Topics: Amphetamine; Animals; Cefoxitin; Corpus Striatum; Dopamine; Limbic System; Phenethylamines; Rats; Receptors, Dopamine; Selegiline | 1990 |
Comparison of the dependence capacity of amphetamine, MK-306 and (-)deprenyl.
Topics: Amphetamine; Animals; Cefoxitin; Learning; Phenethylamines; Rats; Selegiline; Substance-Related Disorders | 1990 |
Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
Topics: Amphetamine; Animals; Catecholamines; Clorgyline; Corpus Striatum; Dopamine; Monoamine Oxidase Inhibitors; Nomifensine; Pargyline; Potassium; Rats; Rats, Inbred Strains; Selegiline; Serotonin; Veratrine | 1990 |
Effect of enantiomers of deprenyl (selegiline) and amphetamine on physical abuse liability and cortical electrical activity in rats.
Topics: Amphetamine; Animals; Body Weight; Cerebral Cortex; Codeine; Electric Conductivity; Electroencephalography; Evoked Potentials; Female; Isomerism; Rats; Rats, Inbred Strains; Reference Values; Selegiline; Substance Withdrawal Syndrome | 1990 |
Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.
Topics: Administration, Oral; Adult; Amphetamine; Blood Pressure; Chromatography, Gas; Double-Blind Method; Electrocardiography; Female; Humans; Injections, Intravenous; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Phenethylamines; Phenylacetates; Random Allocation; Selegiline; Tyramine | 1989 |
Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
Topics: Amphetamine; Animals; Chromatography, Gas; Cytochrome P-450 Enzyme System; Gas Chromatography-Mass Spectrometry; Hydroxylation; In Vitro Techniques; Male; Methamphetamine; Methimazole; Methylcholanthrene; Microsomes, Liver; Monoamine Oxidase Inhibitors; Phenethylamines; Phenobarbital; Proadifen; Rats; Rats, Inbred Strains; Selegiline | 1986 |
Investigation of dopamine content, synthesis, and release in the rabbit retina in vitro: I. Effects of dopamine precursors, reserpine, amphetamine, and L-DOPA decarboxylase and monoamine oxidase inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Dopamine; Female; Levodopa; Male; Monoamine Oxidase Inhibitors; Pargyline; Rabbits; Reserpine; Retina; Selegiline; Tyrosine | 1986 |
Purification and properties of mitochondrial monoamine oxidase type A from human placenta.
Topics: 2,2'-Dipyridyl; Amphetamine; Animals; Cattle; Chromatography; Clorgyline; Disulfides; Electrophoresis, Polyacrylamide Gel; Female; Flavins; Humans; Kinetics; Mitochondria; Molecular Weight; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidation-Reduction; Placenta; Pregnancy; Selegiline; Solubility; Sulfhydryl Compounds | 1985 |
Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl.
Topics: Amphetamine; Animals; Isoenzymes; Kinetics; Liver; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Phenethylamines; Rats; Rats, Inbred Strains; Selegiline; Stereoisomerism | 1985 |
Amphetamine, p-hydroxyamphetamine and beta-phenethylamine in mouse brain and urine after (-)- and (+)-deprenyl administration.
Topics: Amphetamine; Amphetamines; Animals; Biogenic Amines; Brain; Male; Mice; p-Hydroxyamphetamine; Phenethylamines; Selegiline; Stereoisomerism | 1981 |
Long-lasting, true aphrodisiac effect of (-)-deprenyl in sexually sluggish old male rats.
Topics: Aging; Amphetamine; Animals; Aphrodisiacs; Castration; Clorgyline; Copulation; Male; Phenethylamines; Rats; Selegiline; Sexual Behavior, Animal; Time Factors | 1983 |
Clinical and pharmacological problems of deprenyl (selegiline) treatment in Parkinson's disease.
Topics: Amphetamine; Humans; Hydrogen-Ion Concentration; Methamphetamine; Parkinson Disease; Phenethylamines; Selegiline | 1983 |
Discrimination of the amphetamine cue. Effects of A, B and mixed type inhibitors of monoamine oxidase.
Topics: Amphetamine; Animals; Cues; Cyclopropanes; Discrimination Learning; Discrimination, Psychological; Male; Monoamine Oxidase Inhibitors; Rats; Selegiline | 1984 |
Fungal metabolism of (-)-deprenyl and pargyline.
Topics: Amphetamine; Benzylamines; Biotransformation; Mucorales; Pargyline; Phenethylamines; Selegiline | 1981 |
The action of (-) deprenyl on monoamine turnover rate in rat brain.
Topics: Amphetamine; Animals; Brain; Brain Stem; Catecholamines; Corpus Striatum; Dopamine; Female; Male; Norepinephrine; Phenethylamines; Rats; Receptors, Dopamine; Selegiline | 1982 |
The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties.
Topics: Amphetamine; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrogen-Ion Concentration; Levodopa; Methamphetamine; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline | 1982 |
Responses of forebrain neurons to the MAO-B blocker L-deprenyl.
Topics: Acetylcholine; Amphetamine; Animals; Clorgyline; Electrophoresis; Female; gamma-Aminobutyric Acid; Macaca mulatta; Male; Microelectrodes; Monoamine Oxidase; Neurons; Prosencephalon; Rats; Rats, Inbred Strains; Selegiline; Species Specificity | 1995 |
Hair analysis for drugs of abuse. IX. Comparison of deprenyl use and methamphetamine use by hair analysis.
Topics: Administration, Oral; Adult; Amphetamine; Animals; Gas Chromatography-Mass Spectrometry; Hair; Humans; Illicit Drugs; Male; Methamphetamine; Middle Aged; Rats; Selegiline; Stereoisomerism | 1995 |
Sensitive high-performance liquid chromatographic method for the determination of the three main metabolites of selegiline (L-deprenyl) in human plasma.
Topics: Amphetamine; Biotransformation; Chromatography, High Pressure Liquid; Fluorenes; Humans; Indicators and Reagents; Methamphetamine; Quality Control; Selegiline | 1994 |
An enzymatic assay for the MAO-B inhibitor selegiline in plasma.
Topics: Amphetamine; Amphetamines; Animals; Brain; Humans; Hydroxyquinolines; Male; Methamphetamine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selegiline; Spectrometry, Fluorescence | 1994 |
Evaluation of physical dependence liability of l-deprenyl (selegiline) in animals.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Electroencephalography; Female; Male; Rats; Rats, Sprague-Dawley; Selegiline; Stereoisomerism; Substance-Related Disorders; Time Factors | 1994 |
Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies.
Topics: Amphetamine; Amphetamines; Animals; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Rats; Saimiri; Selegiline | 1994 |
(-)-Deprenyl alters the survival of adult murine facial motoneurons after axotomy: increases in vulnerable C57BL strain but decreases in motor neuron degeneration mutants.
Topics: Amphetamine; Animals; Axons; Cell Survival; Facial Nerve; Methamphetamine; Mice; Mice, Inbred A; Mice, Inbred C57BL; Mice, Neurologic Mutants; Motor Neurons; Nerve Degeneration; Selegiline; Species Specificity | 1994 |
Chronic L-deprenyl or L-amphetamine: equal cognitive enhancement, unequal MAO inhibition.
Topics: Amphetamine; Animals; Cognition; Learning; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Wistar; Selegiline; Space Perception; Stimulation, Chemical | 1994 |
Further proof that (-)deprenyl fails to facilitate mesolimbic dopaminergic activity.
Topics: Amphetamine; Animals; Cell-Free System; Corpus Striatum; Dopamine; Female; Limbic System; Male; Motor Activity; Olfactory Bulb; Phenethylamines; Rats; Rats, Wistar; Selegiline; Stereotyped Behavior | 1993 |
Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry.
Topics: Amphetamine; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; Quality Control; Regression Analysis; Selegiline | 1993 |
Methamphetamine and amphetamine derived from the metabolism of selegiline.
Topics: Amphetamine; Gas Chromatography-Mass Spectrometry; Humans; Male; Methamphetamine; Selegiline | 1995 |
Gas chromatographic procedure for simultaneous determination of selegiline metabolites, amphetamine, methamphetamine and demethyl-deprenyl in pig plasma.
Topics: Amphetamine; Amphetamines; Animals; Capsules; Central Nervous System Stimulants; Chromatography, Gas; Female; Indicators and Reagents; Methamphetamine; Monoamine Oxidase Inhibitors; Selegiline; Swine; Tablets | 1995 |
(-) deprenyl attenuates aluminium induced neurotoxicity in primary cortical cultures.
Topics: Aluminum Chloride; Aluminum Compounds; Amphetamine; Animals; Animals, Newborn; Biomarkers; Cell Survival; Cells, Cultured; Cerebral Cortex; Chlorides; L-Lactate Dehydrogenase; Neurons; Neurotoxins; Pargyline; Rats; Rats, Wistar; Selegiline | 1996 |
Differences in some behavioural effects of deprenyl and amphetamine enantiomers in rats.
Topics: Amphetamine; Animals; Avoidance Learning; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Female; Head Movements; Male; Monoamine Oxidase Inhibitors; Motor Activity; Rats; Rats, Wistar; Selegiline; Stereoisomerism; Stereotyped Behavior | 1996 |
Absorption and presystemic metabolism of selegiline hydrochloride at different regions in the gastrointestinal tract in healthy males.
Topics: Administration, Oral; Adult; Amphetamine; Amphetamines; Biological Availability; Cross-Over Studies; Duodenum; Gastric Mucosa; Humans; Ileum; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Selegiline | 1996 |
Metabolism of (-)-deprenyl and PF-(-)-deprenyl in brain after central and peripheral administration.
Topics: Amphetamine; Animals; Brain; Corpus Striatum; Gas Chromatography-Mass Spectrometry; Injections, Subcutaneous; Male; Methamphetamine; Microdialysis; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selegiline; Sensitivity and Specificity | 1996 |
Pharmacokinetics and bioequivalence of the main metabolites of selegiline: desmethylselegiline, methamphetamine and amphetamine after oral administration of selegiline.
Topics: Administration, Oral; Adult; Amphetamine; Amphetamines; Biological Availability; Central Nervous System Stimulants; Half-Life; Humans; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Selegiline; Therapeutic Equivalency | 1997 |
Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells.
Topics: Amphetamine; Animals; Clorgyline; Cocaine; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Isoenzymes; Membrane Potentials; Mesencephalon; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Nomifensine; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Selegiline; Sulpiride | 1997 |
Selegiline for the delivery of small doses of amphetamine.
Topics: Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Child Development Disorders, Pervasive; Humans; Intellectual Disability; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Selegiline | 1997 |
Gas-chromatographic study on the stereoselectivity of deprenyl metabolism.
Topics: Amphetamine; Gas Chromatography-Mass Spectrometry; Humans; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Selegiline; Stereoisomerism | 1998 |
The amphetamine-like reinforcing effect and mechanism of L-deprenyl on conditioned place preference in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Conditioning, Operant; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Reinforcement, Psychology; Selegiline | 1999 |
Stereochemical determination of selegiline metabolites in postmortem biological specimens.
Topics: Accidents, Aviation; Aged; Amphetamine; Antiparkinson Agents; Autopsy; Gas Chromatography-Mass Spectrometry; Humans; Male; Methamphetamine; Selegiline; Stereoisomerism | 1999 |
Analysis of deprenyl metabolites in the rat brain using HPLC-ES-MS.
Topics: Amphetamine; Animals; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Isomerism; Male; Mass Spectrometry; Methamphetamine; Microdialysis; Rats; Rats, Wistar; Selegiline | 1999 |
Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Carrier Proteins; Dopamine; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Selegiline | 1999 |
Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy.
Topics: Adult; Amphetamine; Amphetamines; Biomarkers; Chromatography, Gas; Diagnosis, Differential; Female; Humans; Male; Methamphetamine; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Stereoisomerism; Substance Abuse Detection; Substance-Related Disorders | 1999 |
Stereoselective screening for and confirmation of urinary enantiomers of amphetamine, methamphetamine, designer drugs, methadone and selected metabolites by capillary electrophoresis.
Topics: Amphetamine; Antiparkinson Agents; Designer Drugs; Electrophoresis, Capillary; Fluorescence Polarization Immunoassay; Humans; Methadone; Methamphetamine; Reproducibility of Results; Selegiline; Spectrophotometry, Ultraviolet; Stereoisomerism | 1999 |
Metabolic transformation of deprenyl enantiomers in rats.
Topics: Amphetamine; Animals; Dealkylation; Kidney; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Rats; Rats, Wistar; Selegiline; Stereoisomerism | 1999 |
The effect of a subchronic post-lesion treatment with (-)-deprenyl on the sensitivity of 6-OHDA-lesioned rats to apomorphine and d-amphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Male; Medial Forebrain Bundle; Oxidopamine; Rats; Rats, Sprague-Dawley; Selegiline | 1999 |
Metabolism of N,N-dialkylated amphetamines, including deprenyl, by CYP2D6 expressed in a human cell line.
Topics: Amphetamine; Amphetamines; Benzphetamine; Cell Line; Chromatography, Gas; Cytochrome P-450 CYP2D6; Humans; Methamphetamine; Methylation; Microsomes; Models, Chemical; Selegiline; Transfection | 2000 |
Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Catecholamines; Clorgyline; Corpus Striatum; Dialysis Solutions; Dihydroxyphenylalanine; Dopamine; Dopamine Uptake Inhibitors; Extracellular Space; Guinea Pigs; Homovanillic Acid; Isoenzymes; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperazines; Potassium Chloride; Rats; Selegiline; Synaptosomes; Tritium; Tyrosine 3-Monooxygenase | 2000 |
Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice.
Topics: Allyl Compounds; Amphetamine; Animals; Benzylamines; Clorgyline; Dopamine Agents; Drug Synergism; Feeding Behavior; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Propylamines; Pyridines; Selegiline; Serotonin Antagonists; Substrate Specificity; Tetraethylammonium | 2001 |
Incorporation of selegiline metabolites into hair after oral selegiline intake.
Topics: Administration, Oral; Adult; Amphetamine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; False Positive Reactions; Female; Gas Chromatography-Mass Spectrometry; Hair; Humans; Male; Melanins; Methamphetamine; Monoamine Oxidase Inhibitors; Selegiline; Sensitivity and Specificity; Substance Abuse Detection | 2001 |
Urinary excretion of selegiline N-oxide, a new indicator for selegiline administration in man.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Amphetamines; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Methamphetamine; Models, Chemical; Monoamine Oxidase Inhibitors; Selegiline; Spectrometry, Mass, Electrospray Ionization; Time Factors | 2002 |
Quantitative analysis of selegiline and three metabolites (N-desmethylselegiline, methamphetamine, and amphetamine) in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Topics: Amphetamine; Amphetamines; Chromatography, High Pressure Liquid; Freezing; Humans; Mass Spectrometry; Methamphetamine; Monoamine Oxidase Inhibitors; Reproducibility of Results; Selegiline | 2002 |
An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats.
Topics: Amphetamine; Animals; Benzofurans; Brain Chemistry; Catecholamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dopamine; Drive; Feeding Behavior; Food Deprivation; Hunger; Male; Monoamine Oxidase Inhibitors; Motor Activity; Neurons; Neurotransmitter Agents; Orientation; Propylamines; Rats; Rats, Wistar; Selegiline; Serotonin | 2003 |
Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using a dual cyclodextrin system in rat urine.
Topics: Amphetamine; Animals; Biotransformation; Cyclodextrins; Electrophoresis, Capillary; Ephedrine; Male; Monoamine Oxidase Inhibitors; Phenylpropanolamine; Rats; Rats, Wistar; Reproducibility of Results; Selegiline; Sensitivity and Specificity; Stereoisomerism | 2003 |
Assessment of the N-oxidation of deprenyl, methamphetamine, and amphetamine enantiomers by chiral capillary electrophoresis: an in vitro metabolism study.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Amphetamine; beta-Cyclodextrins; Buffers; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Methamphetamine; Microsomes, Liver; Molecular Structure; Oxidation-Reduction; Oxygenases; Recombinant Proteins; Selegiline; Stereoisomerism | 2004 |
L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Topics: Amphetamine; Animals; Catalase; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Electron Transport Complex I; Hydroxyl Radical; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Selegiline; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase; Uncoupling Agents; Up-Regulation | 2006 |
Amphetamine-induced locomotor activity is reduced in mice following MPTP treatment but not following selegiline/MPTP treatment.
Topics: Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Locomotion; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Neuroprotective Agents; Selegiline | 2006 |
High-performance liquid chromatographic-mass spectrometric determination of methamphetamine and amphetamine enantiomers, desmethylselegiline and selegiline, in hair samples of long-term methamphetamine abusers or selegiline users.
Topics: Amphetamine; Amphetamines; Antiparkinson Agents; Chromatography, High Pressure Liquid; Hair; Humans; Methamphetamine; Parkinson Disease; Selegiline; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection | 2006 |
Pharmacokinetic studies of (-)-deprenyl and some of its metabolites in mouse.
Topics: Administration, Oral; Amphetamine; Amphetamines; Animals; Antiparkinson Agents; Biological Availability; Biotransformation; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Male; Metabolic Clearance Rate; Methamphetamine; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Selegiline | 2007 |
Detection of levorotatory methamphetamine and levorotatory amphetamine in urine after ingestion of an overdose of selegiline.
Topics: Adult; Amphetamine; Biomarkers; Drug Overdose; Gas Chromatography-Mass Spectrometry; Humans; Male; Methamphetamine; Parkinson Disease; Selegiline; Suicide, Attempted | 2008 |
Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease.
Topics: Aged; Amphetamine; Antiparkinson Agents; Drug Substitution; Female; Humans; Indans; Male; Methamphetamine; Middle Aged; Motor Activity; Neuroprotective Agents; Parkinson Disease; Selegiline; Severity of Illness Index; Time Factors | 2013 |
The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease.
Topics: Administration, Oral; Amphetamine; Biological Availability; Drug Evaluation; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Randomized Controlled Trials as Topic; Selegiline; Tablets | 2013 |
[Identification of Methamphetamine Abuse and Selegiline Use: Chiral Analysis of Methamphetamine and Amphetamine in Urine].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Chromatography, Liquid; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; Selegiline; Substance Abuse Detection; Tandem Mass Spectrometry | 2017 |
Pharmacokinetics of selegiline, R-methamphetamine, R-amphetamine, and desmethylselegiline in oral fluid after a single oral administration of selegiline.
Topics: Administration, Oral; Amphetamine; Amphetamines; Humans; Liquid-Liquid Extraction; Methamphetamine; Monoamine Oxidase Inhibitors; Saliva; Selegiline; Substance Abuse Detection | 2019 |
Detection of l-Methamphetamine and l-Amphetamine as Selegiline Metabolites.
Topics: Amphetamine; Central Nervous System Stimulants; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; Republic of Korea; Selegiline; Substance Abuse Detection | 2021 |